← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2013Last known activity
Jan 10, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06676605CollaboratorN/AJan 10, 2023
- NCT04333355CollaboratorPhase 1Apr 15, 2020
- NCT01909336Overall official - principal investigatorPhase 3Jul 1, 2013
- NCT01909336Study directorPhase 3Jul 1, 2013
- NCT01909336CollaboratorPhase 3Jul 1, 2013
Details
- Last known activity
- Jan 10, 2023